These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Progestin-only ECPs on the way to the U.S.
    Journal: Contracept Technol Update; 1999 Mar; 20(3):28-9. PubMed ID: 12321963.
    Abstract:
    As the first dedicated emergency contraceptive pills (ECPs) are being marketed in the US, 2 companies are working to introduce progestin-only pills capable of conferring emergency contraceptive protection. Officials at Gynetics of Somerville, NJ, and Women's Capital Corp. of Seattle, Washington, and Washington, DC, are interested in pursuing dedicated progestin-only products after an international study in 1998 demonstrated the advantages of a levonorgestrel-only EC over the Yuzpe regimen used by Gynetics' Preven Emergency Contraception Kit. Gynetics has begun multinational phase III clinical trials on a levonorgestrel product which is expected to be approved in the US and Canada later in 1999 or in early 2000. Women's Capital Corp. completed the New Drug Application for its product in January and hopes to receive priority review status of 6 months or less. The company expects to submit an application for approval in Canada in the first part of 1999.
    [Abstract] [Full Text] [Related] [New Search]